Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005447 |
ID: | TCMBANKHE005447 |
植物拉丁名: |
|
功能与主治: | To strengthen heart and disinhibit urine, upbear yang and effuse exterior./Edema due to heart disease, arrhythmia, non-eruption of macula, knocks and falls. |
药用植物名: | 金雀儿 |
药用部位: | flower or branchlet |
TCM_ID_id: | 2154 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000635 | sparteine | EBD2202131; DSSTox_CID_3591; 298897D62S; AK122435; NCGC00142614-01; 90-39-1; RL05684; (7S,7aS,14S,14aR)-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; L-SPARTEINE; Ambotz90-39-1; Sparteina; 7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, (7S,7aR,14S,14aS)-; C10783; InChI=1/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12?,13?,14-,15-/m0/s; (7S,7aR,14S,14aS)-Dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; Esparteina; CAS-90-39-1; ST24033390; TL8005816; Spartein; ZINC1408502; AJ-67273; CS-W012901; Alkyl Polyglucoside; KS-00000OBL; Sparteinum; UNII-298897D62S; 6-beta,7-alpha,9-alpha,11-alpha-Pachycarpine; MLS002207055; KB-209108; CHEMBL1908847; 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-; AC1LVZQY; Sparteinum [INN-Latin]; Alkylamphopropionate; 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, [7S-(7alpha,7aalpha,14alpha,14abeta)]-; AKOS016012217; FT-0080874; 6beta,7alpha,9alpha,11alpha-Pachycarpine; Sparteine (-); (6''R'',8''S'',10''R'',12''S'')-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane; MLS000028889; NCGC00181124-02; (-)-Sparteine, >=98.0% (GC); Sparteina [DCIT]; Esparteina [INN-Spanish]; 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-; Sparteine [INN]; CHEBI:28827; (+)-Spartein; DSSTox_RID_77098; DSSTox_GSID_23591; (-)sparteine; Prestwick3_000618; lupinidine; 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine,dodecahydro-, (7S,7aR,14S,14aS)-; SCHEMBL79043; (-)-Sparteine; [7S-(7alpha,7aalpha,14alpha,14abeta)]-Dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; BPBio1_000612; Prestwick_426; (-)-Lupinidine; HMS2096L18; (-) sparteine; Sparteine; (7S,7aR,14S,14aS)-Tetradecahydro-7,14-methanodipyrido[1,2-a:1',2'-e][1,5]diazocine; Lupinidin; NCGC00016346-01; SMR000059203; Tox21_110386_1; EINECS 201-988-8; Genisteine Alkaloid; Sparteine (6CI,8CI); BSPBio_000556; SLRCCWJSBJZJBV-ZQDZILKHSA-N; Tox21_110386; AC1LD8G5 | C15H26N2 | 234.38 g/mol | C1CCN2CC3CC(C2C1)CN4C3CCCC4 |
| TCMBANKIN004057 | Octalupine | BRN 0087896; 4-25-00-00082 (Beilstein Handbook Reference); Lupanine, 13-alpha-hydroxy-; Lupanine, 13alpha-hydroxy- (8CI); Lupanine, hydroxy-; 15358-48-2; SCHEMBL4260109; 13-Hydroxylupanine; Lupanine, hydroxy- (6CI); 13alpha-Hydroxylupanine; (1S,2R,9S,10S,12S)-12-HYDROXY-7,15-DIAZATETRACYCLO[7.7.1.0(2),?.0(1)?,(1)?]HEPTADECAN-6-ONE; 13-alpha-Hydroxylupanine; LUPANINE, 13-HYDROXY-; 7,14-Methano-2H,11H-dipyrido(1,2-a:1',2'-e)(1,5)diazocin-11-one, dodecahydro-2-hydroxy-, (2S-(2alpha,7beta,7abeta,14beta,14aalpha))-; Lupanine, 13alpha-hydroxy-; d-Hydroxylupanine; Alkaloid C 2, from Cadia purpurea; 320ZHE5W55; ZINC5191431; 7,14-Methano-2H,11H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-11-one,dodecahydro-2-hydroxy-, (2S,7S,7aR,14S,14aS)-; NSC 70827; Dodecahydro-2-hydroxy-7,14-methano-2H,11H-dipyrido(1,2-a:1',2'-e)(1,5)diazocin-11-one (2S-(2alpha,7beta,7abeta,14beta,14aalpha))-; BG00615259; Hydroxylupanine; 13-Oxylupanine; 13-Hydroxylupanin; (+)-13-Hydroxylupanine; octalupine; 7,14-Methano-4H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocin-4-one, dodecahydro-9-hydroxy-, (7S-(7alpha,7abeta,9beta,14alpha,14aalpha))-; AC1Q6LQH; 6809-89-8 (hydrochloride); 7,14-Methano-4H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocin-4-one, dodecahydro-9-hydroxy-, (7S-(7alpha,7abeta,9beta,14alpha,14aalpha))- (9CI); LS-88189; InChI=1/C15H24N2O2/c18-12-4-5-16-8-10-6-11(14(16)7-12)9-17-13(10)2-1-3-15(17)19/h10-14,18H,1-9H2/t10?,11?,12-,13-,14-/m0/s; Hydroxylupanin; Oxylupanine; Jamaidine; UNII-320ZHE5W55; Luparine, hydroxy- | C15H24N2O2 | 264.36 g/mol | C1CC2C3CC(CN2C(=O)C1)C4CC(CCN4C3)O |
| TCMBANKIN009190 | lupenone | lupenone ; 1617-70-5; LUPENONE; SCHEMBL1483620; NSC 281807; ZINC04081760; Lup-20(29)-en-3-one (8CI)(9CI); (1R,3aR,4S,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-1-Isopropenyl-3a,5a,5b,8,8,11a-hexamethyl-eicosahydro-cyclopenta[a]chrysen-9-one; AIDS-082905; AIDS082905 | C30H48O | 424.7 g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C |
| TCMBANKIN032416 | methy orselinate | C9H10O4 | |||
| TCMBANKIN033221 | 3'-O-Methylorobol | 5,7-dihydroxy-3-(4-hydroxy-3-methoxy-phenyl)chromen-4-one; 5,7-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-4-chromenone; 5,7-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)chromen-4-one; 5,7-dihydroxy-3-(4-hydroxy-3-methoxy-phenyl)chromone; 3'-o-methylorobol | C16H12O6 | 300.26 | COC1=C(C=CC(=C1)C2=COC3=CC(=CC(=C3C2=O)O)O)O |
| TCMBANKIN036845 | isoquercitrin | BDBM84979; FT-0627504; ISOQUERCITRIN | C21H20O12 | 464.376 | C1(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])C(=O)c4c(c([H])c(O[H])c([H])c4O[H])O1 |
| TCMBANKIN046242 | neoxanthin | (1R,3S)-6-[(3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1S,4S,6R)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenylidene]-1,5,5-trimethyl-cyclohexane-1,3-diol; C08606; all-trans-Neoxanthin; LMPR01070278; 14660-91-4; CHEBI:32446; Neoxanthin; (1R,3S)-6-[(3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1S,4S,6R)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenylidene]-1,5,5-trimethylcyclohexane-1,3-diol; (3S,5R,6R,3'S,5'R,6'S)-6,7-didehydro-5',6'-epoxy-5,6,5',6'-tetrahydro-beta,beta-carotene-3,5,3'-triol; (3S,3'S,5R,5'R,6S,6'R,9Z,15Z)-5,6-Epoxy-6',7'-didehydro-5,6,5',6'-tetrahydro-beta,beta-carotene-3,3',5'-triol | C40H56O4 | 600.87 | CC(=CC=CC=C(C)C=CC=C(C)C=C=C1C(CC(CC1(C)O)O)(C)C)C=CC=C(C)C=CC23C(CC(CC2(O3)C)O)(C)C |
| TCMBANKIN058149 | isoluteolin | orobol; 5,7,3 ', 4'-tetrahydroxy isoflavone; Santol | C15H10O6 | 286.24 g/mol | C1=CC(=C(C=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O)O |
| TCMBANKIN058162 | LDP | nchembio801-comp8; SPBio_001205; Spectrum3_000406; 51-61-6; cMAP_000036; KBio2_006628; Spectrum5_000945; DOPAMINE; KBio3_002867; 3-Hydroxtyramine; KBio3_002962; nchembio705-8; 4-(2-Aminoethyl)benzene-1,2-diol; 3, 4-Dihydroxyphenethylamine hydrochloride; 4-(2-aminoethyl)-pyrocatechol; 62-31-7 (HYDROCHLORIDE); Pyrocatechol, 4-(2-aminoethyl)-; Intropin {[as} hydrochloride]; NSC 173182; 4-(2-Aminoethyl)-1,2-bezenediol; KBioSS_001492; EINECS 200-110-0; cMAP_000065; Lopac-H-8502; KBio2_005052; KBioSS_002393; Dophamine; KBio2_004060; HSDB 3068; L-DOPAMINE; 4-(2-Aminoethyl)pyrocatechol; KW-3-060; BSPBio_001932; AIDS156129; KBioGR_002484; NCGC00096050-02; 3,4-Dihydroxyphenylethylamine; KBio2_004956; Spectrum2_001023; NSC169105 (HYDROCHLORIDE); Spectrum4_000525; (3H)-Dopamine; KBioGR_001129; 3-Hydroxytyramine; C03758; Dopamin; KBio2_007620; Dopaminum [INN-Latin]; m-Hydroxytyramine-; BPBio1_001123; Pyrocatechol, 4-(2-aminoethyl)- (8CI); alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; KBioGR_002388; Biomol-NT_000001; 2-(3,4-dihydroxyphenyl)ethylamine; Lopac0_000586; Hydroxytyramin; DivK1c_000780; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)-1,2-benzenediol; CHEBI:18243; 3,4-dihydroxyphenethylamine; 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI); IDI1_000780; NCGC00015519-01; NSC173182; 1,2-Benzenediol, 4-(2-aminoethyl)-; 50444-17-2; Oprea1_088821; hydroxytyramine; SBB004044; NCGC00096050-01; .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane; Spectrum_001012; Dopamine (USAN)(*hydrochloride*); KBio2_002388; KBio3_001152; nchembio.78-comp16; Oxytyramine; KBio2_001492; KBioSS_002491; KBio1_000780; AIDS-156129; KBio2_002484; NINDS_000780; NCGC00096050-04; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; Dopamina [INN-Spanish]; KBio2_007524; SPECTRUM1505155; a-(3,4-Dihydroxyphenyl)-b-aminoethane; dopamine | C8H11NO2 | 153.18 g/mol | C1=CC(=C(C=C1CCN)O)O |
| TCMBANKIN058626 | lupanine | lupaninium; CHEBI:64261; 2-oxospartein-16-ium; lupanine(1+);(+)-Lupanine;C10772; 550-90-3 | C15H24N2O | 248.36 g/mol | C1CCN2CC3CC(C2C1)CN4C3CCCC4=O |
| TCMBANKIN058833 | zeta-carotene | LS-187070; xi-Carotene; CHEBI:28068; AC1NQXL2; BIWLELKAFXRPDE-WTXAYMOSSA-N; 2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; C05430; (6E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; all-trans-zeta-carotene; zeta-Carotene; Zeta-Carotin; 7,8,7',8'-tetrahydro-psi,psi-carotene; LS-187678; LMPR01070256; 13587-06-9; CHEBI:27362;ζ-carotene | C40H60 | 540.9 g/mol | CC(=CCCC(=CCCC(=CC=CC(=CC=CC=C(C)C=CC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C |
| TCMBANKIN059702 | adonixanthin | C40H54O3 | 582.9 g/mol | CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C(=O)C(CC2(C)C)O)C)C)C | |
| TCMBANKIN060000 | carotol | C15H26O | 222.37 | CC1=CCC2(CCC(C2(CC1)O)C(C)C)C | |
| TCMBANKIN061534 | (-)-sparticarpin | C10531; LMPK12070062; CHEBI:118; DTXSID60331963; (?)-Sparticarpin; AC1L9DGK; (6aR,11aR)-2,3-dimethoxy-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromen-9-ol; 73793-85-8; (-)-Sparticarpin; (?)-sparticarpin | C17H16O5 | 300.3 g/mol | COC1=C(C=C2C(=C1)C3C(CO2)C4=C(O3)C=C(C=C4)O)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab